MODO DUO Electric Pump (B11621, B11673)
Tomy International, Inc. · Decision date Oct 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-16 for MODO DUO Electric Pump (B11621, B11673), a traditional 510(k) submitted by Tomy International, Inc. of Dyersville, Iowa, under K261782. The device falls under regulation 884.5160, classification name Pump, Breast, Powered, product code HGX, in the Obstetrics/Gynecology specialty and review panel. The application was received 05/29/2026 and was not reviewed by a third party; it is not a combination product and no predetermined change control plan was authorized.
SESE in the 510(k) pathway means the device was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record names Guangzhou GLOMED Biological Technology Co., Ltd. as correspondent. The two model numbers B11621 and B11673 appear only in the device name, and the source does not state what distinguishes them or what, if anything, changed relative to the predicate. No summary statement, indications, or performance data are present in the provided material, so the basis for the equivalence determination is unknown.
The page was last updated 10/26/2026. Details of the reviewed components, any comparison device, and labeling remain outside the public information and would require the underlying FDA documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Oct 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261782
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Tomy International, Inc.
- Product code
- HGX
- Decision code
- SESE
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pump, Breast, Powered.
- Applicant
- Tomy International, Inc.
- Product code
- HGX
- FDA device class
- 2
FDA decision timeline
K261782 received
Application receipt date recorded by FDA.
K261782 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HGX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Nenesupply Co., Ltd. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Shenzhen TPH Technology Co., Ltd. | 510(k) clearance | Sep 17, 2026 | FDA | |
| Philips Consumer Lifestyle B.V. | 510(k) clearance | Sep 3, 2026 | FDA | |
| Guangdong Horigen Mother & Baby Products Co., Ltd. | 510(k) clearance | Sep 1, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tomy International, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Dyersville, IA
Sources and methodology
- Original FDA record: K261782
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

